gemfibrozil and puromycin aminonucleoside

gemfibrozil has been researched along with puromycin aminonucleoside in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chen, J; Dai, R; Han, X; Liu, H; Liu, J; Lv, Q; Rao, J; Shen, Q; Sun, L; Xu, H; Zhai, Y	1

Other Studies

1 other study(ies) available for gemfibrozil and puromycin aminonucleoside

Article	Year
PPARα agonist exerts protective effects in podocyte injury via inhibition of the ANGPTL3 pathway. Experimental cell research, 2021, 10-15, Volume: 407, Issue:2 Topics: Actin Cytoskeleton; Angiopoietin-Like Protein 3; Angiopoietin-like Proteins; Animals; Apoptosis; Gemfibrozil; Hypolipidemic Agents; Mice; Mice, Knockout; Podocytes; PPAR alpha; Protective Factors; Pseudopodia; Puromycin Aminonucleoside	2021

Article

Year

PPARα agonist exerts protective effects in podocyte injury via inhibition of the ANGPTL3 pathway.

Experimental cell research, 2021, 10-15, Volume: 407, Issue:2

Topics: Actin Cytoskeleton; Angiopoietin-Like Protein 3; Angiopoietin-like Proteins; Animals; Apoptosis; Gemfibrozil; Hypolipidemic Agents; Mice; Mice, Knockout; Podocytes; PPAR alpha; Protective Factors; Pseudopodia; Puromycin Aminonucleoside

2021